ADMA BIOLOGICS, INC.: accounts_receivable
| Value | {"amount": 99412000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2025-03-31) |
| Status | current |
| Entity | ADMA BIOLOGICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T13:07:04.216257+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/75cc89f1-6260-4798-95aa-7b0afc16de34
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001140361-25-017747Retrieved: 2026-08-19T13:07:04.216257+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001368514/accounts-receivable/2025-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/75cc89f1-6260-4798-95aa-7b0afc16de34
History
- no predecessors — first report